Prodrug Strategies for Paclitaxel

Area of Science:

• Oncology
• Medicinal Chemistry
• Drug Delivery

Background:

• Paclitaxel is a potent anti-tumor agent with broad clinical applications.
• Challenges include poor water solubility and limited tumor cell selectivity.
• Existing limitations hinder optimal therapeutic outcomes.

Purpose of the Study:

• To review strategies for enhancing paclitaxel efficacy.
• To focus on prodrug approaches for improved drug performance.
• To address solubility and selectivity issues of paclitaxel.

Main Methods:

• Literature review of modification strategies for paclitaxel.
• Analysis of small molecule and macromolecule modifications.
• Emphasis on prodrug design and development.

Main Results:

• Various modification strategies have been developed globally.
• Prodrug approaches show significant promise in overcoming paclitaxel's limitations.
• Modified paclitaxel derivatives demonstrate improved properties.

Conclusions:

• Chemical modifications, particularly prodrug strategies, are crucial for enhancing paclitaxel.
• These strategies aim to improve solubility and target selectivity.
• Further development holds potential for more effective cancer therapies.